Betulinic acid and dihydrobetulinic acid derivatives as potent anti-HIV agents. 1996

Y Kashiwada, and F Hashimoto, and L M Cosentino, and C H Chen, and P E Garrett, and K H Lee
Natural Products Laboratory, Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina at Chapel Hill, 27599, USA.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000094062 Betulinic Acid A lupane-type triterpene derivative of betulin which was originally isolated from BETULA or birch tree. It has anti-inflammatory, anti-HIV and antineoplastic activities. 3-Epi-betulinic Acid,3-Hydroxy-lup-20(29)-en-28-oic Acid,3-Hydroxylup-20(29)-en-28-oic Acid,Betulic Acid,3 Epi betulinic Acid
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D012194 RNA-Directed DNA Polymerase An enzyme that synthesizes DNA on an RNA template. It is encoded by the pol gene of retroviruses and by certain retrovirus-like elements. EC 2.7.7.49. DNA Polymerase, RNA-Directed,RNA-Dependent DNA Polymerase,Reverse Transcriptase,RNA Transcriptase,Revertase,DNA Polymerase, RNA Directed,DNA Polymerase, RNA-Dependent,RNA Dependent DNA Polymerase,RNA Directed DNA Polymerase
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014315 Triterpenes A class of terpenes (the general formula C30H48) formed by the condensation of six isoprene units, equivalent to three terpene units. Triterpene,Triterpenoid,Triterpenoids
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015726 Giant Cells Multinucleated masses produced by the fusion of many cells; often associated with viral infections. In AIDS, they are induced when the envelope glycoprotein of the HIV virus binds to the CD4 antigen of uninfected neighboring T4 cells. The resulting syncytium leads to cell death and thus may account for the cytopathic effect of the virus. Giant Cells, Multinucleated,Multinucleated Giant Cells,Polykaryocytes,Syncytium,Syncytia,Cell, Giant,Cell, Multinucleated Giant,Cells, Giant,Cells, Multinucleated Giant,Giant Cell,Giant Cell, Multinucleated,Multinucleated Giant Cell,Polykaryocyte

Related Publications

Y Kashiwada, and F Hashimoto, and L M Cosentino, and C H Chen, and P E Garrett, and K H Lee
February 2012, Bioorganic & medicinal chemistry letters,
Y Kashiwada, and F Hashimoto, and L M Cosentino, and C H Chen, and P E Garrett, and K H Lee
May 2004, Bioorganic & medicinal chemistry letters,
Y Kashiwada, and F Hashimoto, and L M Cosentino, and C H Chen, and P E Garrett, and K H Lee
July 2009, Bioorganic & medicinal chemistry letters,
Y Kashiwada, and F Hashimoto, and L M Cosentino, and C H Chen, and P E Garrett, and K H Lee
February 2014, Bioorganic & medicinal chemistry letters,
Y Kashiwada, and F Hashimoto, and L M Cosentino, and C H Chen, and P E Garrett, and K H Lee
May 2009, Journal of medicinal chemistry,
Y Kashiwada, and F Hashimoto, and L M Cosentino, and C H Chen, and P E Garrett, and K H Lee
April 2010, Journal of medicinal chemistry,
Y Kashiwada, and F Hashimoto, and L M Cosentino, and C H Chen, and P E Garrett, and K H Lee
September 2006, Journal of medicinal chemistry,
Y Kashiwada, and F Hashimoto, and L M Cosentino, and C H Chen, and P E Garrett, and K H Lee
October 2011, Bioorganic & medicinal chemistry letters,
Y Kashiwada, and F Hashimoto, and L M Cosentino, and C H Chen, and P E Garrett, and K H Lee
October 2021, Bioorganic & medicinal chemistry letters,
Y Kashiwada, and F Hashimoto, and L M Cosentino, and C H Chen, and P E Garrett, and K H Lee
January 2005, Trends in molecular medicine,
Copied contents to your clipboard!